Skip to main content
Erschienen in: European Surgery 6/2012

01.12.2012 | Original Article

Parathyroid carcinoma in primary hyperparathyroidism: single institution experience

verfasst von: V. R. Zivaljevic, PhD, R. V. Zivic, MD, A. Dj. Diklic, PhD, B. R. Bukvic, MD, S. B. Tatic, PhD, M. R. Kazic, MD, N. K. Kalezic, PhD, I. R. Paunovic, PhD

Erschienen in: European Surgery | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Summary

Background

Parathyroid carcinoma as a cause of primary hyperparathyroidism is very rare. Clear consensus regarding the optimal management of patients with this condition is not available. We aimed to report our experience with this entity.

Methods

We analyzed medical records of patients who were operated for primary hyperparathyroidism and parathyroid carcinoma in the Centre for Endocrine Surgery in Belgrade, between January 2000 and December 2007.

Results

Seven patients (four men and three women) were operated for parathyroid carcinoma and primary HPT in our institution in this period. The age at initial diagnosis (mean ± SD) was 53.5 ± 7.6 years. All patients had hypercalcemia (mean 3.53 mmol/l) and very elevated parathyroid hormone (mean 1,530 pg/ml). Extirpation of the parathyroid tumor was performed in two patients, while in five patients parathyroidectomy was performed en block with all involved tissue. Average follow up was 47 months. One patient died for another disease, one was found to have increased calcium and parathyroid hormone levels postoperatively, while the remaining five were free of disease.

Conclusions

Surgery remains central in the management of patients with parathyroid carcinoma. Still, further multicentric studies should be performed for consistent treatment guidelines.
Literatur
1.
Zurück zum Zitat Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore). 1992;71:197–205. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore). 1992;71:197–205.
2.
Zurück zum Zitat Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716–26.PubMedCrossRef Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716–26.PubMedCrossRef
3.
Zurück zum Zitat Robert J, Trombetti A, Garcia A, Pache JC, Herrmann F, Spiliopoulos A, et al. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature. Ann Surg Oncol. 2005;12:526–32.PubMedCrossRef Robert J, Trombetti A, Garcia A, Pache JC, Herrmann F, Spiliopoulos A, et al. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature. Ann Surg Oncol. 2005;12:526–32.PubMedCrossRef
5.
Zurück zum Zitat Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86:485–93.PubMedCrossRef Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86:485–93.PubMedCrossRef
6.
Zurück zum Zitat Ou HY, Hung WH, Hsu WH, Yu EH, Wu TJ. Variability of clinical presentations in three cases of parathyroid carcinoma. J Formos Med Assoc. 2003;102:266–69.PubMed Ou HY, Hung WH, Hsu WH, Yu EH, Wu TJ. Variability of clinical presentations in three cases of parathyroid carcinoma. J Formos Med Assoc. 2003;102:266–69.PubMed
7.
Zurück zum Zitat Hundahl S, Fleming I, Fremgen A, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995. Cancer. 1999;86:538–44.PubMedCrossRef Hundahl S, Fleming I, Fremgen A, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995. Cancer. 1999;86:538–44.PubMedCrossRef
8.
Zurück zum Zitat Zivaljevic V, Krgovic K, Tatic S, Havelka M, Dimitrijevic Z, Diklic A, et al. Parathyroid cancer in a hemodialysis patient: a case report. Tumori. 2002;88:430–3.PubMed Zivaljevic V, Krgovic K, Tatic S, Havelka M, Dimitrijevic Z, Diklic A, et al. Parathyroid cancer in a hemodialysis patient: a case report. Tumori. 2002;88:430–3.PubMed
9.
Zurück zum Zitat Cavaco BM, Barros L, Pannett AA, Ruas L, Carvalheiro M, Ruas MM, et al. The hyperparathyroidism-jaw tumor syndrome in a Portuguese kindred. QJM. 2001;94:213–22.PubMedCrossRef Cavaco BM, Barros L, Pannett AA, Ruas L, Carvalheiro M, Ruas MM, et al. The hyperparathyroidism-jaw tumor syndrome in a Portuguese kindred. QJM. 2001;94:213–22.PubMedCrossRef
10.
Zurück zum Zitat Wassif WS, Moniz CF, Friedman E, Wong S, Weber G, Nordenskjold M, et al. Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab. 1993;77:1485–9.PubMedCrossRef Wassif WS, Moniz CF, Friedman E, Wong S, Weber G, Nordenskjold M, et al. Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab. 1993;77:1485–9.PubMedCrossRef
11.
Zurück zum Zitat Imanishi Y, Palanisamy N, Tahara H, Vickery A, Cryns VL, Gaz RD, et al. Molecular pathogenetic analysis of parathyroid carcinoma. J Bone Miner Res. 1999;14:405. Imanishi Y, Palanisamy N, Tahara H, Vickery A, Cryns VL, Gaz RD, et al. Molecular pathogenetic analysis of parathyroid carcinoma. J Bone Miner Res. 1999;14:405.
12.
Zurück zum Zitat Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001;136:878–85.PubMedCrossRef Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001;136:878–85.PubMedCrossRef
13.
14.
Zurück zum Zitat Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109(9):1736–41. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109(9):1736–41.
15.
Zurück zum Zitat Silverberg SJ, Rubin MR, Faiman C, Peacock M, Shoback DM, Smallridge RC, et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab. 2007;92:3803–8.PubMedCrossRef Silverberg SJ, Rubin MR, Faiman C, Peacock M, Shoback DM, Smallridge RC, et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab. 2007;92:3803–8.PubMedCrossRef
16.
Zurück zum Zitat Miki H, Sumitomo M, Inoue H, Kita S, Monden Y. Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis. Surgery. 1996;120:897–901.PubMedCrossRef Miki H, Sumitomo M, Inoue H, Kita S, Monden Y. Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis. Surgery. 1996;120:897–901.PubMedCrossRef
17.
Zurück zum Zitat Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg. 1991;15:738–44.PubMedCrossRef Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg. 1991;15:738–44.PubMedCrossRef
18.
Zurück zum Zitat Shane E, Bilezikian J. Parathyroid carcinoma: a review of 62 patients. Endocr Rev. 1982;3:218–26.PubMedCrossRef Shane E, Bilezikian J. Parathyroid carcinoma: a review of 62 patients. Endocr Rev. 1982;3:218–26.PubMedCrossRef
19.
Zurück zum Zitat Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16:724–31. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16:724–31.
20.
Zurück zum Zitat Khan MW, Worcester EM, Straus FH 2nd, Khan S, Staszak V, Kaplan EL. Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg. 2004;199:312–9.PubMedCrossRef Khan MW, Worcester EM, Straus FH 2nd, Khan S, Staszak V, Kaplan EL. Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg. 2004;199:312–9.PubMedCrossRef
21.
Zurück zum Zitat Holmes EC, Morton DL, Ketcham AS. Parathyroid carcinoma: a collective review. Ann Surg. 1969;169:631–40.PubMedCrossRef Holmes EC, Morton DL, Ketcham AS. Parathyroid carcinoma: a collective review. Ann Surg. 1969;169:631–40.PubMedCrossRef
22.
Zurück zum Zitat Ippolito G, Palazzo FF, Sebag F, De Micco C, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg. 2007;94(5):566–70. Ippolito G, Palazzo FF, Sebag F, De Micco C, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg. 2007;94(5):566–70.
23.
Zurück zum Zitat Pelizzo MR, Piotto A, Beramasco A, Rubello D, Casara D. Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience. Minerva Endocrinol. 2001;26:23–9.PubMed Pelizzo MR, Piotto A, Beramasco A, Rubello D, Casara D. Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience. Minerva Endocrinol. 2001;26:23–9.PubMed
24.
Zurück zum Zitat Sanchez SA, Iglesias AMA. Diagnostic-therapeutic management of parathyroid carcinoma. An Med Interna. 2002;9:644–8. Sanchez SA, Iglesias AMA. Diagnostic-therapeutic management of parathyroid carcinoma. An Med Interna. 2002;9:644–8.
25.
Zurück zum Zitat Chow E, Tsang RW, Brierley JD, Filice S. Parathyroid carcinoma—the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys. 1998;41:569–72.PubMedCrossRef Chow E, Tsang RW, Brierley JD, Filice S. Parathyroid carcinoma—the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys. 1998;41:569–72.PubMedCrossRef
Metadaten
Titel
Parathyroid carcinoma in primary hyperparathyroidism: single institution experience
verfasst von
V. R. Zivaljevic, PhD
R. V. Zivic, MD
A. Dj. Diklic, PhD
B. R. Bukvic, MD
S. B. Tatic, PhD
M. R. Kazic, MD
N. K. Kalezic, PhD
I. R. Paunovic, PhD
Publikationsdatum
01.12.2012
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 6/2012
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-012-0180-x

Weitere Artikel der Ausgabe 6/2012

European Surgery 6/2012 Zur Ausgabe